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11 Abstract
12 Background
13 Peripheral arterial disease (PAD) is common and symptoms can be
14 debilitating and lethal. Risk management, exercise, radiological and sur-
15 gical intervention are all valuable therapies, but morbidity and mortality
16 rates from this disease are increasing. Circulatory enhancement can be
17 achieved using simple medical electronic devices, with claims of minimal
18 adverse side effects. The evidence for these is variable, prompting a
19 review of the available literature.
20 Methods
21 Embase and Medline were interrogated for full text articles in humans and
22 written in English. Any external medical devices used in the management
23 of peripheral arterial disease were included if they had objective outcome
24 data.
25 Results
26 Thirty-one papers met inclusion criteria, but protocols were heterogenous.
27 The medical devices reported were intermittent pneumatic compression
28 (IPC), electronic nerve (NMES) or muscle stimulators (EMS), and gal-
29 vanic electrical dressings.
30 In patients with intermittent claudication, IPC devices increase popli-
31 teal artery velocity (49–70 %) and flow (49–84 %). Gastrocnemius EMS
32 increased superficial femoral artery flow by 140 %. Over 4.5–6 months
33 IPC increased intermittent claudication distance (ICD) (97–150 %) and
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34 absolute walking distance (AWD) (84–112 %), with an associated
35 increase in quality of life. NMES of the calf increased ICD and AWD
36 by 82 % and 61–150 % at 4 weeks, and 26 % and 34 % at 8 weeks.
37 In patients with critical limb ischaemia IPC reduced rest pain in
38 40–100 % and was associated with ulcer healing rates of 26 %. IPC had
39 an early limb salvage rate of 58–83 % at 1–3 months, and 58–94 % at
40 1.5–3.5 years. No studies have reported the use of EMS or NMES in the
41 management of CLI.
42 Conclusion
43 There is evidence to support the use of IPC in the management of
44 claudication and CLI. There is a building body of literature to support
45 the use of electrical stimulators in PAD, but this is low level to date.
46 Devices may be of special benefit to those with limited exercise capacity,
47 and in non-reconstructable critical limb ischaemia. Galvanic stimulation
48 is not recommended.
49 Keywords
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152 Background
53 Peripheral arterial disease (PAD) is common,
54 and often co-exists with cardio-respiratory dis-
55 ease, stroke, and diabetes [1]. Its incidence is
56 estimated at 7–14 % in the general population
57 [1, 2], increasing with age to approximately 20 %
58 in the over-seventies [3]. It is associated with
59 progressive and profound effects on mobility,
60 skin integrity and quality of life [4]. Significant
61 clinical manifestations include intermittent clau-
62 dication, rest pain, gangrene, and limb loss. Risk
63 management, exercise, radiological and surgical
64 intervention are all valuable therapies, but mor-
65 bidity and mortality rates from this disease are
66 increasing [3, 5, 6]. Due to the nature of the
67 disease, exercise tolerance can be limited by
68 performance status. Invasive procedures carry
69 with them significant risks, and patients with
70 diffuse disease are often not suitable for
71 revascularisation [7].
72 Maximal medical and surgical therapy has
73 been shown in the past to be augmented by the
74 use of medical devices such as intermittent
75pneumatic compression [8]. Electronic muscular
76stimulation (EMS) and neuromuscular stimula-
77tion (NMES) devices can cause contraction of
78the leg muscles in similar ways to IPC, and may
79have similar beneficial effects. The supporting
80evidence for neuromuscular stimulation in
81peripheral arterial disease is variable in scientific
82and clinical content or relevance, and prompted
83further exploration.
84This review aims to identify and analyse
85studies of non-invasive haemodynamic devices
86applicable to this cohort, and extrapolate evi-
87dence with a view to modulating current
88clinical practice. This is also relevant in the
89light of recent technological advances of
90electrical stimulation devices, becoming more
91portable, affordable, and accessible to health
92professionals.
2 93Methods
94A systematic review of Embase and Medline was
95undertaken, with the search string:
388 K.J. Williams et al.
96 (“device” OR “electric” OR “stimulation” OR
97 “pneumatic” OR “compression” OR “IPC”)
98 AND (“peripheral arterial diseas*” OR
99 “isch*” OR “peripheral vascular diseas*”
100 OR “claudication”) AND (“leg” OR “limb”
101 OR “foot”) (No Related Terms)
102
103 The search was performed on 8th July 2013
104 and repeated by the Royal College of Surgeons of
105 England library. A PRISMA diagram shows the
106 paper selection process (Fig. 1).
107 Abstracts were screened and included or
108 eliminated by title, abstracts and full texts were
109 screened for the peripheral use of non-invasive
110 medical devices in humans for the management
111 of lower limb peripheral arterial disease.
112 Inclusion criteria were clinical or haemo-
113 dynamic data related to the device use. Exclusion
114 criteria were animal studies, studies pertaining
115 to epidemiology, diagnosis or pure imaging.
116 Non-electrical devices were excluded (e.g. vas-
117 cular closure devices), as were invasive therapies
118 such as endovascular intervention, spinal cord/
119 epidural stimulation, and extracorporeal limb
120 perfusion. Functional electric stimulation for
121 spinal cord injury was excluded.
3 122Results
123Thirty-one papers met criteria for inclusion and
124were grouped according to indication for use.
125Despite multiple devices, protocols and trial
126designs, inferences have been drawn. Table 1
127details the studies, with numerical results data





133Six external compression devices were reported:
134five pneumatic (Circulator Boot, Circulator Boot
135Company, the AV Impulse, Novamedix Ltd, the
136DVT-30, Huntleigh Healthcare, the Art Assist
1371000, ACI Medical, the ArterialFlow, DJO),
138and one which uses an external compressive
139band (FM220TM, FlowMedic, Israel). Pressure
140settings varied from very low (55 mmHg in Cir-
141culation Boot) to high (120 mmHg in ArtAssist).
Fig. 1 PRISMA diagram













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































142 All applied pressure anatomically to the calf,
143 some additionally to the foot or thigh.
4.2144 Electrical Stimulators
145 A mixture of transcutaneous electrical
146 stimulators were reported. The VeinoplusTM
147 (Adrem Tech, France) delivers electricity to the
148 gastrocnemius muscle (1–250 Hz, 50 V, pulse
149 width 240 ms), whilst the three NMES/TENS
150 machines can operate at variable settings and be
151 placed over muscles or nerves (MedicompexTM,
152 Medicompex SA, NeuroTrac TM TENS, Verity
153 Medical Ltd, TENS SM1, Schwa-Medico). The
154 Micro-ZTM, Prizm Medical Inc is a galvanic
155 electrical stimulator (50 V, pulse width 100 μs,
156 sub-threshold for sensation and muscle contrac-
157 tion). Direct current is applied to a specific body
158 area by a conducting garment, with contact aided
159 by an electrolyte solution.
5160 Evidence by Indication
5.1161 Intermittent Claudication
162 (Also Described as “Stable
163 Claudicants”, or Fontaine
164 Stage 2)
165 The immediate effect of IPC devices is to
166 increase popliteal artery velocity (49–70 %)
167 [11, 12] and flow (49–84 %) [10–12, 18, 20]
168 when compared to baseline levels. When used
169 for a prolonged period of time they have also
170 been shown to improve popliteal artery flow by
171 3–36 % [13, 16]. Electrical stimulation of the
172 gastrocnemius has been shown to increase super-
173 ficial femoral artery flow by 140 %, although
174 there were a wide range of flow changes in the
175 small cohort study [25].
176 There were a wide variety of protocols, how-
177 ever over the course of 4.5–6 months IPC was
178 shown to increase ICD (97–150 %) and AWD
179 (84–112 %) by clinically significant distances,
180 with the benefits persisting over 12 months
181 [13, 15, 16]. External compression of the calf
182achieved an increase of 85 % and 76 % in ICD
183and AWD, which was significant when compared
184to negative controls, and sustained at 3 months
185[19]. NMES of the calf muscles, using the
186Medicompex, increased ICD and AWD by
18782 % and 61–150 % over 4 weeks [23, 24], and
18826 % and 34 % over 8 weeks [22]. These trials
189were small, but results were significant when
190compared to a sham device group.
191Delis et al. showed an increase in quality of
192life at 5 months with IPC therapy, whilst the best
193medical therapy groups scores were unchanged
194[16]. These gains were sustained at 12 months
195post-treatment.
5.2 196Critical Limb Ischaemia
197Studies suggest that IPC reduces rest pain in
19840–100 % [29, 31]. One trial evaluated the effect
199of high frequency TENS on the relief of
200laboratory-induced tourniquet ischaemic pain
201[35]. The blinded use of the TENS machine
202delayed the onset of pain, reduced pain levels,
203and increased endurance of pain over a period
204of several minutes. This was significant when
205compared to sham-placebo. However, the
206feasibility of clinical use of TENS in peripheral
207arterial disease does not appear to have been
208explored.
209IPC treatment was shown to have ulcer
210healing rates of 26 % [29]. Vella et al. offer a
21179 % “favourable outcome” at 40 days, a loose
212term which covers decreased ulcer size, complete
213healing, or improved sufficiently to allow
214revascularisation [28]. Blood flux to the skin of
215the foot, as evidenced by laser Doppler, was
216increased significantly over 5 IPC cycles in a
217cohort of 20 subjects [30].
218IPC had an early limb salvage rate of 58–83 %
219at 1–3 months, and 58–94 % at 1.5–3.5 years
220[28, 29, 31, 32, 39]. Beirne et al. quoted an
221amputation rate of 3 % at 18 months, and a
222mortality rate of 21 %, but do not compare to
223controls [34].
224No studies have reported the use of EMS or
225NMES in the management of CLI.
402 K.J. Williams et al.
5.3226 Post Revascularisation
227 Two IPC devices have been investigated for their
228 utility in circulatory support after surgical
229 revascularisation. Application to the foot for
230 7 days after femorodistal bypass in 5 subjects led
231 to reduced swelling and increased haemodynamic
232 parameters in the femoral and popliteal vessels
233 over controls not treated with IPC [36]. No numer-
234 ical data to support this is given, and conflicts of
235 interest have not been declared. The 2002 paper
236 looks at grafted arteriopaths (femoropopliteal and
237 femorodistal bypass) approximately 18 months
238 post-operation, and shows that a single treatment
239 with IPC increases foot skin blood flux from
240 baseline equally to controls, during device
241 operation [14].
5.4242 Galvanic stimulation - a special
243 mention
244 There were few published clinical studies
245 using galvanic electrical stimulation in periph-
246 eral arterial disease. Peter et al. investigated
247 subjects who had impaired peripheral perfusion
248 and microvascular insufficiency, as measured by
249 laser Doppler and transcutaneous oximeter
250 [37]. He demonstrated an increase in skin blood
251 flux and oxygen tension in 11 diabetic patients
252 with impaired microcirculation after 5 mins of
253 stimulation, which dropped back to baseline
254 after stimulation ceased. Another study of
255 40 randomised and controlled subjects looked at
256 the healing of diabetic neuropathic foot ulcers
257 when subjected to a nocturnal program of gal-
258 vanic skin stimulation over 12 weeks [38]. There
259 was no significant difference in wound healing
260 rate, time to complete healing, or limb salvage
261 between test and control groups.
6262 Discussion
263 There is evidence to support the use of IPC in
264 the management of intermittent claudication,
265 with clinically important changes in treadmill
266distances seen with regular use. The greatest
267volume of published supporting research lies
268behind the ArtAssist device. The benefit of
269linking compressions to cardiac cycle, such as
270with the Circulator Boot, has not been shown to
271be clinically important at this point in time.
272This review suggests that long term EMS or
273NMES can positively affect clinical parameters
274of symptomatic peripheral arterial disease. It
275remains to be seen how effective long term
276NMES is for treating symptomatic intermittent
277claudication, and if this is equivalent to
278supervised exercise training, or a useful adjunct.
279NMES may have additional benefits over exer-
280cise alone. There is evidence in animal models
281that changes in muscle stimulation can affect
282muscle fibre differentiation, although this has
283not been replicated in adult humans [40]. Nerve
284cross-union experiments have shown the
285ability of fast and slow twitch muscles to
286change their contraction times and metabolic
287activity, according to changes in innervation
288[40, 41]. Forst et al. showed a positive effect on
289diabetic microvascular disease, with NMES able
290to increase foot temperature, but this was blunted
291in cases of peripheral neuropathy [42]. High level
292evidence will only be provided by an adequately
293powered comparative clinical trial.
294The evidence presented here suggests that IPC
295reduces pain and increases limb salvage in criti-
296cal limb ischaemia, and that this would be
297directly applicable to the clinical management
298of these patients were revascularisation is not
299possible.
300Electrical stimulation devices have evolved
301significantly since their initial introduction as a
302simple pair of electrodes attached to a generator
303box, with significant safety concerns – they had
304been known to cause burns at the interface site,
305or explode in the operating theatre [43]. They are
306decreasing in size and cost, some are portable
307and do not interfere with mobilisation. The dura-
308tion and length of NMES protocol remains con-
309tentious, with some advocating three 20 min
310stimulation sessions per day, others 1 h continu-
311ous stimulation per day. However, results in
312these small studies do appear to be both benefi-
313cial and similar [44]. There is no general
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314 consensus as to an ideal protocol, which may be
315 best explored in a combination of laboratory and
316 clinical trials.
317 TENS machines have been used in the man-
318 agement of pain, and are thought to work through
319 a gating mechanism, effectively switching off
320 downstream pain signals by providing an alter-
321 native stimulus. This can be used in the treatment
322 of pain symptoms of any cause, and do appear to
323 be effective in the short-term treatment of
324 ischaemic pain. Conclusions beyond this are not
325 supported by the literature.
326 There is little evidence to support the use of
327 galvanic stimulation in this patient cohort.
7328 Conclusion
329 There are many devices that are clinically rele-
330 vant to the vascular specialist managing patients
331 with peripheral arterial disease. A working
332 knowledge of available devices, especially IPC
333 and NMES, expands the range of therapies avail-
334 able for management of symptomatic disease,
335 and may be of special benefit to those with lim-
336 ited exercise capacity. The use of IPC in
337 non-reconstructable critical limb ischaemia is
338 particularly useful for limb salvage.
339 Medical devices for the assistance in manage-
340 ment of all forms of PAD are emerging as impor-
341 tant non-invasive tools. If they are to cement
342 their roles in this management strategy, more
343 robust research in the form of randomised con-
344 trolled studies will be required to add to their
345 evidence base.
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